Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-24 @ 4:52 PM
NCT ID:
NCT03904550
Eligibility Criteria:
Inclusion Criteria:
* 18-80 years old
* Severe renal impairment (CrCl \< 30 mL/min)
* Undergoing non-emergent surgery that requires neuromuscular blockade
* Planned extubation in the operating room immediately after surgery
* American Society of Anesthesiologists (ASA) physical status classification 3 to 4
* Willing and able to consent in English or Spanish
* No personal history of neuromuscular disease
Exclusion Criteria:
* Age less than 18 or older than 80
* Patient does not speak English or Spanish
* Planned postoperative intubation/ventilation
* Allergy to sugammadex, neostigmine, glycopyrrolate, cisatracurium, or rocuronium
* Family or personal history of malignant hyperthermia
* Patient refusal
* Pregnant or nursing women
* "Stat" (emergent) cases
* Pre-existing muscle weakness of any etiology
* Patients on toremifene (a selective estrogen receptor modulator)
* Women on oral contraceptives who do not wish to use a non-hormonal method of contraception for 7 days following surgery
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03904550
Study Brief:
Protocol Section:
NCT03904550